Glenmark Pharmaceuticals informs about media release

21 May 2024 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India’.

The above information is a part of company’s filings submitted to BSE. 

Glenmark Pharma Share Price

2029.70 0.10 (0.00%)
31-Dec-2025 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.65
Dr. Reddys Lab 1270.50
Cipla 1508.10
Zydus Lifesciences 913.35
Lupin 2111.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×